» Articles » PMID: 30804785

Fibroblast Growth Factors in Depression

Overview
Journal Front Pharmacol
Date 2019 Feb 27
PMID 30804785
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Major depressive disorder (MDD) is one of the most serious diseases and now becomes a major public health problem in the world. The pathogenesis of depression remains poorly understood. Fibroblast growth factors (FGFs) belong to a large family of growth factors that are involved in brain development during early periods as well as maintenance and repair throughout adulthood. In recent years, studies have found a correlation between the members of the FGF system and depression. These signaling molecules may be expected to be biomarkers for the diagnosis and prognosis of MDD, and may provide new drug targets for the treatment of depression. Here, we reviewed the correlation between some members of the FGF system and depression.

Citing Articles

Exploring endocrine FGFs - structures, functions and biomedical applications.

Phan P, Ternier G, Edirisinghe O, Kumar T Int J Biochem Mol Biol. 2024; 15(4):68-99.

PMID: 39309613 PMC: 11411148. DOI: 10.62347/PALK2137.


Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.

Jaber M, Kahwaji H, Nasr S, Baz R, Kim Y, Fakhoury M Adv Exp Med Biol. 2024; 1456:359-378.

PMID: 39261438 DOI: 10.1007/978-981-97-4402-2_18.


Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study.

Lesperance P, Desbeaumes Jodoin V, Drouin D, Racicot F, Miron J, Longpre-Poirier C Int J Mol Sci. 2024; 25(5).

PMID: 38473935 PMC: 10931975. DOI: 10.3390/ijms25052679.


Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.

Kumar A, Nader M, Deep G Pharmacol Rev. 2024; 76(2):199-227.

PMID: 38351075 PMC: 10877757. DOI: 10.1124/pharmrev.122.000788.


Bile acid signalling and its role in anxiety disorders.

Chen S, Shao Q, Chen J, Lv X, Ji J, Liu Y Front Endocrinol (Lausanne). 2023; 14:1268865.

PMID: 38075046 PMC: 10710157. DOI: 10.3389/fendo.2023.1268865.


References
1.
Garces A, Nishimune H, Philippe J, Pettmann B, Delapeyriere O . FGF9: a motoneuron survival factor expressed by medial thoracic and sacral motoneurons. J Neurosci Res. 2000; 60(1):1-9. DOI: 10.1002/(SICI)1097-4547(20000401)60:1<1::AID-JNR1>3.0.CO;2-P. View

2.
Nishimura T, Nakatake Y, Konishi M, Itoh N . Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta. 2000; 1492(1):203-6. DOI: 10.1016/s0167-4781(00)00067-1. View

3.
Kanda T, Iwasaki T, Nakamura S, Kurokawa T, Ikeda K, Mizusawa H . Self-secretion of fibroblast growth factor-9 supports basal forebrain cholinergic neurons in an autocrine/paracrine manner. Brain Res. 2000; 876(1-2):22-30. DOI: 10.1016/s0006-8993(00)02563-4. View

4.
Nakatake Y, Hoshikawa M, Asaki T, Kassai Y, Itoh N . Identification of a novel fibroblast growth factor, FGF-22, preferentially expressed in the inner root sheath of the hair follicle. Biochim Biophys Acta. 2001; 1517(3):460-3. DOI: 10.1016/s0167-4781(00)00302-x. View

5.
Ford-Perriss M, Abud H, Murphy M . Fibroblast growth factors in the developing central nervous system. Clin Exp Pharmacol Physiol. 2001; 28(7):493-503. DOI: 10.1046/j.1440-1681.2001.03477.x. View